Advanced Micro Devices surges 18% on strong earnings
AMD stock surged 18% after reporting Q1 earnings that beat estimates on surging data center AI demand, but supply constraints and valuation concerns remain flashpoints.
Objective Facts
Advanced Micro Devices delivered Q1 2026 results on May 5, 2026, with revenue of $10.3 billion (38% YoY) and non-GAAP EPS of $1.37 (43% YoY increase), both beating Wall Street expectations. Data center revenue increased 57% to $5.8 billion, driven by strong EPYC processor and Instinct GPU demand. CEO Lisa Su raised the long-term server CPU market growth forecast to exceed 35% annually from 18%, citing accelerating demand for agentic AI workloads. Wall Street responded with widespread upgrades: Goldman Sachs to Buy at $450, Roth Capital to $500, and multiple other major firms to $375-$450+ targets. However, HSBC's Frank Lee had downgraded the stock days earlier due to valuation concerns and TSMC capacity constraints that could limit GPU shipments 15-20% below demand.
Left-Leaning Perspective
CNBC's Jim Cramer pushed back against the HSBC downgrade, saying 'Advanced Micro has CPUs, and CPUs are what is being used by agents,' and predicted the stock will see meaningful upside as demand for CPUs continues to surge. Cramer argued on the CNBC Investing Club's Morning Meeting that AMD remains well-positioned due to surging demand for CPUs and GPUs as agentic AI systems expand, dismissing valuationist concerns about the stock's run. Cramer's counterargument hinges on agentic AI—the next wave of autonomous systems that can complete tasks with limited human oversight—which makes CPUs more critical than in earlier AI spending stages when GPUs dominated, and he believes AMD's CPU position gives it an underappreciated edge. Cramer highlighted that the race to build data centers and deploy complex AI systems known as agentic AI has ignited fervent demand for central processing units faster than manufacturers can keep up, and AMD makes both CPUs and GPUs, positioning it uniquely for this shift. When confronted with HSBC's supply constraint argument, Cramer dismissed the worry, arguing that supply tightness actually reinforces the broader imbalance that supports AMD's pricing power. Cramer's framing emphasizes the structural nature of the agentic AI demand shift and positions supply constraints as a positive signal rather than a limiting factor. He does not engage deeply with valuation metrics or the question of whether market expectations are already priced into AMD's 18% surge.
Right-Leaning Perspective
HSBC analyst Frank Lee downgraded AMD to Hold from Buy, citing limited upside after the stock's recent rally and highlighting capacity constraints as a key challenge; he believes fundamentals remain solid but the recent run leaves limited room for further gains in the near term. Frank Lee stated HSBC does 'not expect an upside earnings surprise from AMD's upcoming 1Q26 earnings results, despite strong demand,' noting the stock has already priced in much of the good news and expects 'limited upside opportunities for AMD to significantly surpass market expectations in 2026.' Lee's core concern is AMD's dependence on TSMC's 3-nanometer node, expecting tightness to persist through the first half of 2027, capping AMD's unit shipments even as demand accelerates, and believing it will be difficult for AMD to gain additional capacity allocations. Morgan Stanley analyst Joseph Moore raised his price target to $410 from $360 but maintained a Hold rating, saying that while near-term results were slightly ahead of expectations, his longer-term forecasts remain largely unchanged, suggesting the stock's surge has already reflected the bullish case. HSBC flagged that AMD is trading ~33x 2027 earnings versus ~19x before, technical RSI 84 signals overbought conditions, and if guidance is merely in line with expectations, the multiple can compress quickly. HSBC revised down its full-year CPU and AI GPU revenue forecasts for AMD due to uncertainty around supply constraints and demand digestion; while the firm expects supply pressures to ease over time through TSMC capacity expansion, until conditions improve concretely, market expectations for AMD may face downward revisions. The contrarian view emphasizes that market expectations are already baked into the stock price and that supply-side realities could constrain near-term growth regardless of demand strength. This perspective values prudence over momentum.
Deep Dive
The specific angle of this story is AMD's ability to execute on agentic AI demand while navigating TSMC supply constraints. The fundamental question is not whether demand is real—both sides agree on that—but whether the current valuation and stock surge reflect realistic expectations or have already captured the upside. Lisa Su explicitly attributed the earnings beat to a 'shifting of the workload' from training large language models to inference and agentic AI, with server CPU market growth raised from 18% to over 35% annually by 2030. Unlike Nvidia, AMD has long been a leading maker of CPUs, which are enjoying a major renaissance as agentic AI shifts compute needs, and AMD and Intel announced they'll pair up on a new instruction set for x86 CPUs. This is a genuinely new structural development—the prior AI cycle favored GPUs almost exclusively, but orchestration of agentic workloads demands CPU horsepower. The valuation pressure is real: AMD trades at ~33x 2027 earnings versus ~19x before the 2026 run, and the RSI 84 signals technical overbought conditions. However, CNBC's Partsinevelos also noted that AMD's data center revenue increased only modestly sequentially, raising questions about whether TSMC capacity constraints could limit near-term growth despite strong demand, though AMD's Helios architecture and MI GPUs position it as a top Nvidia competitor. The tension is between structural CPU demand visibility (which Cramer emphasizes) and near-term execution risk (which HSBC emphasizes). AMD and Meta signed an agreement to deploy 6 GW of Instinct GPUs, with Intel's next-generation Xeon processor Diamond Rapids delayed until mid-2027, meaning AMD's next-gen EPYC Venice processors will face almost no same-generation competition in the critical H2 2026 window. This is bullish execution optionality. Yet TSMC's 3nm production lines are 'essentially fully booked,' and while TSMC is expanding 3nm and 2nm capacity, supply shortages will likely persist through 2027. The window to capitalize on competitive advantage is genuine but time-bound. If TSMC's 2nm capacity comes online as planned in 2027, supply constraints lift and earnings upside could flow through, but HSBC said it would need 'better foundry capacity allocation visibility by late 2026' before turning constructive. What to watch: (1) Whether AMD's Q2 2026 guidance validates the revised 35% CPU market growth thesis or signals execution challenges. (2) Whether Meta's 6 GW MI450 deployment ramps on schedule in H2 2026. (3) Whether TSMC's capacity announcements provide clearer visibility on advanced node allocation. If execution holds, Cramer's case is right and the stock has further to run; if supply constraints bite, Morgan Stanley's cautious Hold stance will prove prescient.